m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00570)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
SRSF10
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
YTH domain-containing protein 1 (YTHDC1) [READER]
Representative RNA-seq result indicating the expression of this target gene regulated by YTHDC1 | ||
Cell Line | MOLM-13 cell line | Homo sapiens |
Treatment: shYTHDC1 MOLM13 cells
Control: shControl MOLM13 cells
|
GSE168565 | |
Regulation |
|
logFC: -6.79E-01 p-value: 2.34E-06 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Kaposi's sarcoma-associated herpesvirus(KSHV) productive lytic replication plays a pivotal role in the initiation and progression of Kaposi's sarcoma tumors. m6A sites in RTA pre-mRNA crucial for splicing through interactions with YTHDC1, SRSF3 and Serine/arginine-rich splicing factor 10 (SRSF10). m6A in regulating RTA pre-mRNA splicing but also suggest that KSHV has evolved a mechanism to manipulate the host m6A machinery to its advantage in promoting lytic replication. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Kaposi's sarcoma | ICD-11: 2B57 | ||
Pathway Response | Spliceosome | hsa03040 | ||
In-vitro Model | TIVE-KSHV (KSHV-infected telomerase-immortalized human umbilical vein endothelial cells (TIVE-KSHV cells)) | |||
iSLK-BAC16 cells (Kaposi's sarcoma cells carrying the recombinant KSHV bacterial artificial chromosome 16 (BAC16) (iSLK-BAC16 cells)) | ||||
HUVEC-C | Normal | Homo sapiens | CVCL_2959 | |
Kaposi's sarcoma [ICD-11: 2B57]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Kaposi's sarcoma-associated herpesvirus(KSHV) productive lytic replication plays a pivotal role in the initiation and progression of Kaposi's sarcoma tumors. m6A sites in RTA pre-mRNA crucial for splicing through interactions with YTHDC1, SRSF3 and Serine/arginine-rich splicing factor 10 (SRSF10). m6A in regulating RTA pre-mRNA splicing but also suggest that KSHV has evolved a mechanism to manipulate the host m6A machinery to its advantage in promoting lytic replication. | |||
Responsed Disease | Kaposi's sarcoma [ICD-11: 2B57] | |||
Target Regulator | YTH domain-containing protein 1 (YTHDC1) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | Spliceosome | hsa03040 | ||
In-vitro Model | TIVE-KSHV (KSHV-infected telomerase-immortalized human umbilical vein endothelial cells (TIVE-KSHV cells)) | |||
iSLK-BAC16 cells (Kaposi's sarcoma cells carrying the recombinant KSHV bacterial artificial chromosome 16 (BAC16) (iSLK-BAC16 cells)) | ||||
HUVEC-C | Normal | Homo sapiens | CVCL_2959 | |